Showing results (31-40 of 422) with videos related to
Sort By:
Pageof 43
Expert Review of Anticancer Therapy|September 16, 2011
Therapeutic potential of PARP inhibitors for metastatic breast cancerSheeba Irshad, Alan Ashworth, Andrew TuttEndocrine-Related Cancer|November 30, 2007
Pregnancy and the risk of breast cancerKara Britt, Alan Ashworth, Matthew SmalleyNature|October 1, 2010
Translating cancer research into targeted therapeuticsJ S de Bono, Alan AshworthCurrent Opinion in Pharmacology|June 16, 2005
Targeting the DNA repair defect of BRCA tumoursNicholas Turner, Andrew Tutt, Alan AshworthThe Oncologist|June 19, 2016
DNA Repair Deficiency Is Common in Advanced Prostate Cancer: New Therapeutic OpportunitiesMallika Dhawan, Charles J Ryan, Alan AshworthBMC Molecular Biology|October 24, 2002
Retroviral vectors for establishing tetracycline-regulated gene expression in an otherwise recalcitrant cell lineParaic A Kenny, Tariq Enver, Alan AshworthNature Reviews. Clinical Oncology|August 12, 2010
Making the best of PARP inhibitors in ovarian cancerSusana Banerjee, Stan B Kaye, Alan AshworthBMC Cancer|January 12, 2005
Receptor and secreted targets of Wnt-1/beta-catenin signalling in mouse mammary epithelial cellsParaic A Kenny, Tariq Enver, Alan AshworthCritical Reviews in Oncology/Hematology|December 10, 2016
PARP inhibitor combination therapyAmy Dréan, Christopher J Lord, Alan AshworthCell Cycle (Georgetown, Tex.)|July 8, 2008
Dissecting resistance to endocrine therapy in breast cancerChristopher J Lord, Elizabeth Iorns, Alan AshworthPageof 43